Suppr超能文献

与翻译起始因子eIF-4A具有序列同源性的核蛋白。

Nuclear protein with sequence homology to translation initiation factor eIF-4A.

作者信息

Ford M J, Anton I A, Lane D P

机构信息

Imperial Cancer Research Fund Clare Hall Laboratories, Herts, UK.

出版信息

Nature. 1988 Apr 21;332(6166):736-8. doi: 10.1038/332736a0.

Abstract

The p68 protein is a highly conserved nuclear antigen that is thought to be important in the regulation of cell growth and division. It is found in dividing cells of all mammals and amphibians tested, but not in quiescent cells. The protein shows a distinct granular distribution in the nucleus and is induced within four hours of serum stimulation of quiescent mouse fibroblasts. The p68 protein was first identified because of its specific immunological cross-reaction with the DNA tumour virus nuclear oncogene SV40 large T, detected with the anti-SV40 large T monoclonal antibody DL3C4, now renamed PAb204. Sequencing of human complementary DNA coding for the growth-regulated p68 nuclear protein has revealed the molecular basis for its cross-reaction with SV40 large T antigen and its extensive homology with the translation initiation factor eIF-4A. The sequence similarity between p68 and eIF-4A is interesting because eIF-4A acts as an ATP-dependent RNA helicase and T antigen is an ATP-dependent DNA helicase. We suggest that p68 could be a DNA or RNA helicase in the cell nucleus which is involved in replication, transcription or RNA processing and is required for cell growth.

摘要

p68蛋白是一种高度保守的核抗原,被认为在细胞生长和分裂的调节中起重要作用。在所有测试的哺乳动物和两栖动物的分裂细胞中都能发现它,但在静止细胞中则没有。该蛋白在细胞核中呈现出明显的颗粒状分布,并且在静止的小鼠成纤维细胞受到血清刺激后4小时内被诱导产生。p68蛋白最初是因其与DNA肿瘤病毒核癌基因SV40大T抗原的特异性免疫交叉反应而被鉴定出来的,该反应是用抗SV40大T单克隆抗体DL3C4检测到的,现在重新命名为PAb204。对编码生长调节型p68核蛋白的人类互补DNA进行测序,揭示了其与SV40大T抗原发生交叉反应以及与翻译起始因子eIF-4A具有广泛同源性的分子基础。p68与eIF-4A之间的序列相似性很有趣,因为eIF-4A作为一种依赖ATP的RNA解旋酶,而T抗原是一种依赖ATP的DNA解旋酶。我们认为p68可能是细胞核中的一种DNA或RNA解旋酶,参与复制、转录或RNA加工,并且是细胞生长所必需的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验